Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

64.43 

0.48 0.8%

as of Jun 13 '19

52 Week Range:

52.31 76.68


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company operates through four segments: Domestic Consumer Products Business, Overseas Consumers Products Business, Direct Marketing Business, and Other Business. The Domestic Consumer Products segment offers products that include Kurocure, a remedy for dark and rough spots on elbows and knees; Hishimore, a medication for dry skin; Nightmin Nasal Respiration Tape, a product that helps to breathe through nose; Sawaday Kaoru Stick Aroma, a home fragrance for aromatic oils; Keshimin Cream EX, a prescription cream for spots; and Bioil, a skincare oil. This segment also offers Eyebon, an eye wash solution with corneal healing and protective ingredients; Bisrat Gold, an obesity therapeutic drug; Inochi no Haha A, a women's health medicine; Chikunain, a sinusitis medicine; Dusmock, a Kampo medicine that ameliorates persistent coughing and bronchitis; Sarasaty, a panty liner; Bluelet, a toilet bowl cleaner and freshener in the household products category; Keshimin, a skincare product for spots; and Madame Juju, a skincare cream in the skincare category. The Overseas Consumer Products segment provides products, such as body warmers; Netsusama sheet, a cooling gel sheet for the forehead; and Ammeltz, a topical anti-inflammatory. The Direct Marketing Business segment engages in the mail-order sale of nutritional supplements, skincare products, and other products by telephonic orders and online. The Other Business segment is involved in the transportation business; manufacture and distribution of plastic containers; insurance agency operations; and real estate management, and advertising planning and production activities. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Dec '16 Dec '17 Dec '18
Equity (BVPS) 7.10
8.29
9.49
10.91
11.18
10.68
12.62
14.42
13.86
16.47
growth rate 16.8% 14.5% 15.0% 2.5% -4.5% 18.2% 14.3% -2.0% 18.8%
Earnings BIT 18,123.00
17,918.00
18,261.00
18,909.00
22,809.00
26,191.00
growth rate -1.1% 1.9% 3.6% 20.6% 14.8%
Avg.PE 25.09
30.31
31.53
30.87
growth rate 20.8% 4.0% -2.1%
ROA 7.15
7.19
7.01
8.31
7.98
7.50
6.97
7.18
7.25
8.01
growth rate 0.6% -2.5% 18.5% -4.0% -6.0% -7.1% 3.0% 0.5% 10.5%
ROE 11.53
11.49
10.61
12.14
11.24
10.18
9.34
9.57
10.31
11.26
growth rate -0.4% -7.7% 14.4% -7.4% -9.4% -8.3% 2.5% 3.8% 9.2%
ROIC 11.28
11.07
10.30
11.94
11.07
10.02
9.20
9.40
10.15
11.09
growth rate -1.9% -7.0% 15.9% -7.3% -9.5% -8.2% 2.2% 3.9% 9.3%
Cur. Ratio 1.84
2.18
2.57
2.71
2.74
3.09
3.23
3.30
2.62
2.81
growth rate 18.5% 17.9% 5.5% 1.1% 12.8% 4.5% 2.2% -10.9% 7.3%
Quick Ratio 1.41
1.77
2.11
2.27
2.27
2.63
2.76
2.80
2.27
2.47
growth rate 25.5% 19.2% 7.6% 0.0% 15.9% 4.9% 1.5% -10.0% 8.8%
Leverage 1.64
1.56
1.47
1.45
1.37
1.35
1.33
1.33
1.42
1.39
growth rate -4.9% -5.8% -1.4% -5.5% -1.5% -1.5% 0.0% 3.3% -2.1%
Balance Sheet Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Dec '16 Dec '17 Dec '18
Acct.Receivable 30,760.00
34,372.00
35,923.00
36,013.00
47,000.00
49,998.00
53,255.00
growth rate 11.7% 4.5% 0.3% 30.5% 6.4% 6.5%
Acct.Payable 11,577.00
11,368.00
13,521.00
13,660.00
16,018.00
17,500.00
17,776.00
growth rate -1.8% 18.9% 1.0% 17.3% 9.3% 1.6%
Cur.Assets 94,353.00
105,614.00
115,990.00
120,347.00
128,646.00
142,346.00
155,058.00
growth rate 11.9% 9.8% 3.8% 6.9% 10.7% 8.9%
Total Assets 157,106.00
170,919.00
186,331.00
188,997.00
201,234.00
218,831.00
230,989.00
growth rate 8.8% 9.0% 1.4% 6.5% 8.7% 5.6%
Cash 45,862.00
51,748.00
58,449.00
61,428.00
58,173.00
64,990.00
74,456.00
growth rate 12.8% 13.0% 5.1% -5.3% 11.7% 14.6%
Inventory 11,197.00
10,531.00
12,484.00
13,951.00
12,805.00
13,289.00
13,643.00
growth rate -6.0% 18.6% 11.8% -8.2% 3.8% 2.7%
Cur.Liabilities 34,477.00
34,216.00
35,890.00
36,481.00
46,975.00
54,274.00
55,215.00
growth rate -0.8% 4.9% 1.7% 28.8% 15.5% 1.7%
Liabilities 42,236.00
43,967.00
46,722.00
46,974.00
57,915.00
65,021.00
64,741.00
growth rate 4.1% 6.3% 0.5% 23.3% 12.3% -0.4%
Equity 139,587.00
141,948.00
143,319.00
153,810.00
166,248.00
growth rate 1.7% 1.0% 7.3% 8.1%
Common Shares 82.00
82.00
82.00
82.00
82.00
82.00
82.00
81.00
3,450.00
79.00
79.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -1.2% 4,159.3% -97.7% 0.0%
Cash Flow Statement Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Dec '16 Dec '17 Dec '18
Capital Expenditures 2,512.00
2,885.00
3,100.00
3,381.00
3,800.00
2,841.00
3,419.00
growth rate 14.9% 7.5% 9.1% 12.4% -25.2% 20.3%
Cash Dividends 3,552.00
3,837.00
5,225.33
4,343.00
4,818.00
growth rate 8.0% 36.2% -16.9% 10.9%
Cash From OA 9,242.00
13,513.00
15,445.00
14,329.00
21,462.66
22,350.00
20,007.00
growth rate 46.2% 14.3% -7.2% 49.8% 4.1% -10.5%
FCF per Share 0.93
1.21
1.14
1.53
0.91
0.83
1.07
1.13
1.27
1.60
growth rate 30.1% -5.8% 34.2% -40.5% -8.8% 28.9% 5.6% 6.0% 26.0%
Sale Purchase of Stock 1,624.00
1,624.00
121.33
352.00
growth rate 0.0% -92.5% 190.1%
FCF 10,058.00
12,334.00
11,003.00
15,158.00
6,367.00
10,169.00
11,767.00
10,282.00
17,662.66
19,145.00
16,306.00
growth rate 22.6% -10.8% 37.8% -58.0% 59.7% 15.7% -12.6% 71.8% 8.4% -14.8%
Income Statement Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Dec '16 Dec '17 Dec '18
Sales 121,532.00
127,293.00
128,344.00
137,211.00
152,654.00
156,761.00
167,479.00
growth rate 4.7% 0.8% 6.9% 11.3% 2.7% 6.8%
Op.Income 12,176.00
18,123.00
17,918.00
18,261.00
18,909.00
22,809.00
26,191.00
growth rate 48.8% -1.1% 1.9% 3.6% 20.6% 14.8%
IBT 20,056.00
18,756.00
20,879.00
22,572.00
25,303.00
growth rate -6.5% 11.3% 8.1% 12.1%
Net Income 12,176.00
12,307.00
12,448.00
13,466.00
15,333.00
15,863.00
18,023.00
growth rate 1.1% 1.2% 8.2% 13.9% 3.5% 13.6%
EPS 107.90
112.94
113.99
143.18
148.69
150.28
152.73
165.30
201.03
227.95
growth rate 4.7% 0.9% 25.6% 3.9% 1.1% 1.6% 8.2% 10.3% 13.4%
Gross Profit 69,800.00
73,100.00
73,626.00
79,693.00
89,850.00
95,523.00
103,120.00
growth rate 4.7% 0.7% 8.2% 12.8% 6.3% 8.0%
R&D 5,289.00
5,788.00
9,909.00
7,239.00
7,031.00
growth rate 9.4% 71.2% -27.0% -2.9%

Quarterly Statements

Item Name Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Earnings BIT 5,568.00
6,035.00
7,960.00
6,628.00
5,288.00
growth rate 8.4% 31.9% -16.7% -20.2%
Balance Sheet Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Acct.Receivable 38,535.00
42,687.00
48,974.00
53,255.00
41,026.00
growth rate 10.8% 14.7% 8.7% -23.0%
Acct.Payable 16,210.00
16,844.00
17,964.00
17,776.00
16,910.00
growth rate 3.9% 6.7% -1.1% -4.9%
Cur.Assets 135,194.00
138,543.00
144,250.00
155,058.00
141,571.00
growth rate 2.5% 4.1% 7.5% -8.7%
Total Assets 210,665.00
217,101.00
224,818.00
230,989.00
220,457.00
growth rate 3.1% 3.6% 2.7% -4.6%
Cash 67,593.00
64,997.00
63,093.00
74,456.00
71,911.00
growth rate -3.8% -2.9% 18.0% -3.4%
Inventory 15,042.00
16,951.00
18,158.00
13,643.00
17,145.00
growth rate 12.7% 7.1% -24.9% 25.7%
Cur.Liabilities 45,998.00
46,789.00
48,507.00
55,215.00
47,128.00
growth rate 1.7% 3.7% 13.8% -14.7%
Liabilities 56,628.00
57,550.00
59,738.00
64,741.00
54,764.00
growth rate 1.6% 3.8% 8.4% -15.4%
Equity 154,037.00
159,551.00
165,080.00
166,248.00
165,693.00
growth rate 3.6% 3.5% 0.7% -0.3%
Common Shares 3,450.00
3,450.00
3,450.00
3,450.00
3,450.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Income Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Sales 33,715.00
38,963.00
43,090.00
51,711.00
33,735.00
growth rate 15.6% 10.6% 20.0% -34.8%
Op.Income 5,568.00
6,035.00
7,960.00
6,628.00
5,288.00
growth rate 8.4% 31.9% -16.7% -20.2%
IBT 5,403.00
5,323.00
9,037.00
5,540.00
5,212.00
growth rate -1.5% 69.8% -38.7% -5.9%
Net Income 3,821.00
3,808.00
6,380.00
4,014.00
3,683.00
growth rate -0.3% 67.5% -37.1% -8.3%
Gross Profit 21,277.00
25,064.00
26,843.00
29,936.00
21,287.00
growth rate 17.8% 7.1% 11.5% -28.9%
R&D 7,031.00
7,031.00
7,031.00
7,031.00
growth rate 0.0% 0.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (55.66)

YOY Growth Grade:

D (46.64)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 30.93 30.93
EPS / Growth 2.08

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 6.4%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.4% 6.4% 6.4%
Future PE 0.01 14.59 14.59
Future EPS 3.88 3.88 3.88
Value Price
MOS %
0.01
-100.0%
14.00
-78.3%
14.00
-78.3%
MOS Price 0.00 7.00 7.00
IRT 16.92 16.92 16.92

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.